$42.51 -$3.45 (-7.5%)

04:30 PM EDT on 04/01/20

Bluebird Bio Inc. (NASDAQ:BLUE)

CAPS Rating: 4 out of 5

Current Price $42.51 Mkt Cap $2.4B
Open $44.85 P/E Ratio 0.00
Prev. Close $42.51 Div. (Yield) $0.00 (0.0%)
Daily Range $42.29 - $46.72 Volume 919,250
52-Wk Range $38.95 - $99.36 Avg. Daily Vol. 968,247

Caps

How do you think NASDAQ:BLUE will perform against the market?

Add Stock to CAPS Watchlist

All Players

257 Outperform
16 Underperform
 

All-Star Players

83 Outperform
6 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:BLUE Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

Exanut (40.80)
Submitted January 17, 2016

They have pulled off what no other company was able to do successfully to date: gene therapy. This is a paradigm shift in treating hereto untreateable diseases. I don't expect the road to be easy as far as investing with this company, but I do think… More

TMFFlygal (99.32)
Submitted December 08, 2015

Selling for a while after the huge drop today, good for a trade

NASDAQ:BLUE VS S&P 500 (SPY)

Fools bullish on NASDAQ:BLUE are also bullish on:

Fools bearish on NASDAQ:BLUE are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about BLUE.

Recs

0
Member Avatar KBOKSOFT (42.29) Submitted: 2/9/2020 9:01:34 PM : Outperform Start Price: $88.10 NASDAQ:BLUE Score: -26.12

Lottery Ticket

Recs

0
Member Avatar wrciii (51.33) Submitted: 1/3/2020 7:32:05 PM : Outperform Start Price: $87.16 NASDAQ:BLUE Score: -27.95

David Nie Wedbush

Recs

0
Member Avatar jbonefish (46.93) Submitted: 6/14/2019 10:51:02 PM : Outperform Start Price: $118.05 NASDAQ:BLUE Score: -49.08

In the “age of miracles” Bluebird is out in front in applying the science and focused on the types of diseases (single gene mutations) that are most likely to result in breakthrough treatments initially. Rather than being a good moonshot story, BLUE is doing the work that will solve problems for patients - that is a better recipe for long term financial success than a good story.

Leaderboard

Find the members with the highest scoring picks in BLUE.

Score Leader

DoubleBagel

DoubleBagel (35.79) Score: +669.10

The Score Leader is the player with the highest score across all their picks in BLUE.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. CommodityBuyer < 20 7/10/2015 Underperform 5Y $160.69 -73.55% +18.78% +92.32 0 Comment
portefeuille12 29.42 4/16/2014 Outperform 5Y $19.11 +122.45% +32.65% +89.79 0 Comment
MotleyFolJohn < 20 2/2/2015 Underperform 1Y $93.98 -54.77% +23.37% +78.13 1 Comment
GreenAB 43.16 3/5/2015 Underperform NS $106.20 -59.97% +16.89% +76.86 0 Comment
portefeuille2 99.13 4/11/2014 10/31/2019 Outperform 5Y $20.74 +104.97% +35.43% +69.54 0 Comment
portefeuille3 97.10 4/11/2014 Outperform 5Y $20.74 +104.97% +35.54% +69.43 0 Comment
johninmadison 79.50 4/7/2014 Outperform 5Y $21.07 +101.76% +32.51% +69.24 0 Comment
farmpride 88.39 4/3/2018 5/23/2019 Underperform 1Y $160.50 -73.51% -4.84% +68.68 0 Comment
baselineace 20.58 11/13/2017 11/30/2018 Underperform 5Y $151.50 -71.94% -4.26% +67.68 0 Comment
portefeuille6 99.53 4/11/2014 Outperform 5Y $20.91 +103.30% +35.72% +67.58 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for BLUE.